ArticleNeurology and therapy2026

Sustained Efficacy of Eptinezumab in Participants with Migraine for Whom Prior Preventive Treatments Failed and Who Self-reported Psychiatric Comorbidities: Post Hoc Analysis of the Placebo-controlled DELIVER Trial.

Patricia Pozo-Rosich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.